Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer Patients

Not Applicable

Completed

• Conditions: Oncology

• Registration Number: NCT03951090
• Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Brief Summary

This study prospectively evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in a cohort of non-electively hospitalized older (\> 70 years) adults with cancer.

Detailed Description

This study evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in non-electively hospitalized older (\> 70 years) adults with cancer. Participants will be randomly assigned to the GARRT group, or the control group. All participants will fill out user friendly questionnaire called the geriatric assessment. The results of the geriatric assessment will be given to the physicians of participants in the GARRT group in real-time. The physicians of participants in the control group will not receive real time results.

This study will compare the referral rates of participants in each group to determine if providing real-time results of the geriatric assessment impact referral rates.

Study Timeline

• Study Start: 2016-04-25
• Primary Completion: 2018-04-24
• Study Completion: 2018-04-24
• Status Verified: 2019-05
• Study First Submitted: 2019-05-13
• Study First Submitted QC: 2019-05-14
• Last Update Submitted: 2019-05-14
• Study First Posted: 2019-05-15
• Last Update Posted: 2019-05-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 148

Inclusion Criteria

• Age 70 years or older.
• English speaking.
• Admitted to UNC Hospitals non-electively within 72 hours.
• Biopsy proven solid tumor or myeloma or lymphoma.
• Newly diagnosed cancer patients for whom active cancer directed therapy is planned within the next six months or patients on active cancer directed therapy either currently or within the previous 6 months.
• Signed written IRB-approved informed consent.

Exclusion Criteria

• Patients meeting any of the following exclusion criteria at baseline will be excluded from study participation. Patients with a life expectancy <6 weeks
• Patients who are <48 hours post-surgery.
• Patients who are admitted to an intensive care setting.
• Patients with acute myeloma lymphoma (AML) or other high grade hematologic malignancies.
• Patients undergoing bone marrow transplant or admitted to the bone marrow transplant unit.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Referral rate for GA-identified deficits in intervention and control groups	2 years	Number of participants with at least one referral for a GA-idenfied deficit

Secondary Outcome Measures

Name	Time	Method
Referral to Physical and Occupational therapy	2 years	Number of times physical and occupation therapy referral was given in Intervention and Control group
Referral to Geriatic Consultation	2 years	Number of times a Geriatric Consultation referral was given in Intervention and Control group
Referral to Clinical Pharmacist	2 years	Number of times Clinical Pharmacist referral was given in Intervention and Control group
Referral to Nutritionist	2 years	Number of times Nutritionist referral was given in Intervention and Control group
Referral to psyhcosocial support team	2 years	Number of times psychosocial support referral was given in Intervention and Control group
Physician Reported New information	2 years	Number of times physicians answer "yes" to the questions "did report provide new information about patient deficits that would warrant a referral"
Physician Reported Satisfaction	2 years	Number of times physician indicate "yes" report was helpful when asked "Is this report useful"

Trial Locations

Locations (1)

UNC Lineberger Comprehensive Cancer Center; 🇺🇸 Chapel Hill, North Carolina, United States